Inhibitors of p53 and HIF-prolyl-4-hydroxylases provide mitochondrial protection in a model of oxytosis
Mitochondrial dysfunction and demise are hallmarks of many neurological disorders and neurodegenerative diseases. Since mitochondria are the key organelles providing energy, they are regarded as the power house of the cell. Under conditions of stress, mitochondria regulate the ‘point of no return’...
Pharmakologie und Toxikologie
Keine Tags, Fügen Sie den ersten Tag hinzu!
4. Natarajan, R., Salloum, F.N., Fisher, B.J., Kukreja, R.C. & Fowler, A.A. Hypoxia inducible factor-1 activation by prolyl 4-hydroxylase-2 gene silencing attenuates myocardial ischemia reperfusion injury. Circulation research 98, 133– 140 (2006).
7. Morris, E.J. et al. Cyclin-dependent kinases and P53 pathways are activated independently and mediate Bax activation in neurons after DNA damage. The Journal of neuroscience : the official journal of the Society for Neuroscience 21, 5017–5026 (2001).
10. Murray-Zmijewski, F., Lane, D.P. & Bourdon, J.-C. p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress. Cell death and differentiation 13, 962–972 (2006).
12. Vanden Berghe, T., Linkermann, A., Jouan-Lanhouet, S., Walczak, H. & Vandenabeele, P. Regulated necrosis: the expanding network of non-apoptotic cell death pathways. Nature reviews. Molecular cell biology 15, 135–147 (2014).
16. Rohrbach, S., Simm, A., Pregla, R., Franke, C. & Katschinski, D.M. Age- dependent increase of prolyl-4-hydroxylase domain (PHD) 3 expression in human and mouse heart. Biogerontology 6, 165–171 (2005).
17. Racay, P., Tatarkova, Z., Drgova, A., Kaplan, P. & Dobrota, D. Effect of ischemic preconditioning on mitochondrial dysfunction and mitochondrial p53 translocation after transient global cerebral ischemia in rats. Neurochemical research 32, 1823–1832 (2007).
22. Yang, L.-Y. et al. Post-trauma administration of the pifithrin-α oxygen analog improves histological and functional outcomes after experimental traumatic brain injury. Experimental neurology 269, 56–66 (2015).
24. Speer, R.E. et al. Hypoxia-inducible factor prolyl hydroxylases as targets for neuroprotection by "antioxidant" metal chelators: From ferroptosis to stroke. Free Radic. Biol. Med. 62, 26–36 (2013).
29. Yukawa, K., Tanaka, T., Tsuji, S. & Akira, S. Regulation of transcription factor C/ATF by the cAMP signal activation in hippocampal neurons, and molecular interaction of C/ATF with signal integrator CBP/p300. Brain research. Molecular brain research 69, 124–134 (1999).
30. Rabinowitz, M.H. Inhibition of hypoxia-inducible factor prolyl hydroxylase domain oxygen sensors: tricking the body into mounting orchestrated survival and repair responses. Journal of medicinal chemistry 56, 9369–9402 (2013).
37. Endo, H., Saito, A. & Chan, P.H. Mitochondrial translocation of p53 underlies the selective death of hippocampal CA1 neurons after global cerebral ischaemia. Biochemical Society transactions 34, 1283–1286 (2006).
39. Wolpaw, A.J. et al. Modulatory profiling identifies mechanisms of small molecule- induced cell death. Proceedings of the National Academy of Sciences of the United States of America 108, E771-80 (2011).
40. Keramaris, E., Hirao, A., Slack, R.S., Mak, T.W. & Park, D.S. Ataxia telangiectasia-mutated protein can regulate p53 and neuronal death independent of Chk2 in response to DNA damage. The Journal of biological chemistry 278, 37782–37789 (2003).
49. Gilman, C.P. et al. p53 is present in synapses where it mediates mitochondrial dysfunction and synaptic degeneration in response to DNA damage, and oxidative and excitotoxic insults. Neuromolecular Med. 3, 159–172 (2003).
50. Steckley, D. et al. Puma is a dominant regulator of oxidative stress induced Bax activation and neuronal apoptosis. The Journal of neuroscience : the official journal of the Society for Neuroscience 27, 12989–12999 (2007).
53. Chou, J., Greig, N.H., Reiner, D., Hoffer, B.J. & Wang, Y. Enhanced survival of dopaminergic neuronal transplants in hemiparkinsonian rats by the p53 inactivator PFT-α. Cell Transplant 20, 1351–1359 (2011).
64. Neitemeier, S., Ganjam, G.K., Diemert, S. & Culmsee, C. Pifithrin-α provides neuroprotective effects at the level of mitochondria independently of p53 inhibition. Apoptosis : an international journal on programmed cell death 19, 1665–1677 (2014).
68. Adaptaquin is an inhibitor of oxygen-sensing prolyl-hydroxylase domain enzymes that abrogates ATF4-dependent death and improves outcomes from brain hemorrhage, submitted Neitemeier S # , Oppermann S # , Laino V # , Jelinek A, Ganjam GK, Dolga AM,
69. van Heemst, D., den Reijer, P M & Westendorp, R G J. Ageing or cancer: a review on the role of caretakers and gatekeepers. European journal of cancer (Oxford, England : 1990) 43, 2144–2152 (2007).
73. Behl, C., Hovey, L., Krajewski, S., Schubert, D. & Reed, J.C. BCL-2 prevents killing of neuronal cells by glutamate but not by amyloid beta protein. Biochemical and biophysical research communications 197, 949–956 (1993).
75. Neitemeier S, Laino V, Oppermann S, Ganjam GK, Dolga AM, Culmsee C: Bid links ferroptosis to mitochondrial cell death pathways in neurons. DPhG Jahrestagung 2014, Frankfurt, Germany, 24.-26.09.2014
78. Ganjam GK, Dolga AM, Neitemeier S, Bolte K, Höllerhage M, Oertel WE, Hoeglinger GU, Culmsee C: Caspase inhibition mitigates alpha synuclein cytotoxicity and mitochondrial demise in human dopaminergic neurons. Society for Neuroscience Annual Meeting, Neuroscience 2014, Washington, USA, 15.-19.11.2014
80. Sato, H., Tamba, M., Ishii, T. & Bannai, S. Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins. The Journal of biological chemistry 274, 11455–11458 (1999).
86. Murphy, T.H., Miyamoto, M., Sastre, A., Schnaar, R.L. & Coyle, J.T. Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress. Neuron 2, 1547–1558 (1989).
87. Ganjam GK, Dolga AM, Neitemeier S, de Andrade A, Bolte K, Oertel W, Höglinger GU, Culmsee C: Human dopaminergic neurons as a model system for Parkinson's disease. 8th International Symposium on Neuroprotection and Neurorepair, Magdeburg, Germany, 09.-12.04.2014
90. Straub, J.A., Lipscomb, E.A., Yoshida, E.S. & Freeman, R.S. Induction of SM- 20 in PC12 cells leads to increased cytochrome c levels, accumulation of cytochrome c in the cytosol, and caspase-dependent cell death. Journal of neurochemistry 85, 318–328 (2003).
91. Lee, D.W. et al. Inhibition of prolyl hydroxylase protects against 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity: model for the potential involvement of the hypoxia-inducible factor pathway in Parkinson disease. The Journal of biological chemistry 284, 29065–29076 (2009).
92. Neitemeier S, Dolga AM, Karuppagounder S, Ratan R, Culmsee C: Inhibitors of HIF- proly-4-hydroxylases (HIF-PHD) mediate mitochondrial protection and prevent oxytosis in neuronal cells. Society for Neuroscience Annual Meeting, Neuroscience 2014, Washington, USA, 15.-19.11.2014
93. Andersen, H.H., Johnsen, K.B. & Moos, T. Iron deposits in the chronically inflamed central nervous system and contributes to neurodegeneration. Cellular and molecular life sciences : CMLS 71, 1607–1622 (2014).
95. Morrison, R.S. et al. Loss of the p53 tumor suppressor gene protects neurons from kainate-induced cell death. The Journal of neuroscience : the official journal of the Society for Neuroscience 16, 1337–1345 (1996).
96. Kim, G.W., Kondo, T., Noshita, N. & Chan, P.H. Manganese superoxide dismutase deficiency exacerbates cerebral infarction after focal cerebral ischemia/reperfusion in mice: implications for the production and role of superoxide radicals. Stroke; a journal of cerebral circulation 33, 809–815 (2002).
100. Endo, H., Kamada, H., Nito, C., Nishi, T. & Chan, P.H. Mitochondrial translocation of p53 mediates release of cytochrome c and hippocampal CA1 neuronal death after transient global cerebral ischemia in rats. The Journal of neuroscience : the official journal of the Society for Neuroscience 26, 7974–7983 (2006).
107. Zhu, X. et al. Novel p53 Inactivators with Neuroprotective Action: Syntheses and Pharmacological Evaluation of 2-Imino-2,3,4,5,6,7-hexahydrobenzothiazole and 2-Imino-2,3,4,5,6,7-hexahydrobenzoxazole Derivatives ⊥. J. Med. Chem. 45, 5090–5097 (2002).
108. Copin, J.C., Gasche, Y. & Chan, P.H. Overexpression of copper/zinc superoxide dismutase does not prevent neonatal lethality in mutant mice that lack manganese superoxide dismutase. Free radical biology & medicine 28, 1571– 1576 (2000).
112. Kelly, K.J. P53 Mediates the Apoptotic Response to GTP Depletion after Renal Ischemia-Reperfusion: Protective Role of a p53 Inhibitor. Journal of the American Society of Nephrology 14, 128–138 (2003).
114. Zaman, K. et al. Protection from oxidative stress-induced apoptosis in cortical neuronal cultures by iron chelators is associated with enhanced DNA binding of hypoxia-inducible factor-1 and ATF-1/CREB and increased expression of glycolytic enzymes, p21(waf1/cip1), and erythropoietin. The Journal of neuroscience : the official journal of the Society for Neuroscience 19, 9821–9830 (1999).
132. Siddiq, A. et al. Selective inhibition of hypoxia-inducible factor (HIF) prolyl- hydroxylase 1 mediates neuroprotection against normoxic oxidative death via HIF- and CREB-independent pathways. J. Neurosci. 29, 8828–8838 (2009).
135. Takeda, K. et al. Placental but not heart defects are associated with elevated hypoxia-inducible factor alpha levels in mice lacking prolyl hydroxylase domain protein 2. Molecular and cellular biology 26, 8336–8346 (2006).
142. Oriowo, B. et al. Targeted gene deletion of prolyl hydroxylase domain protein 3 triggers angiogenesis and preserves cardiac function by stabilizing hypoxia inducible factor 1 alpha following myocardial infarction. Current pharmaceutical design 20, 1305–1310 (2014).
154. Kang, Y., Tiziani, S., Park, G., Kaul, M. & Paternostro, G. Cellular protection using Flt3 and PI3Kα inhibitors demonstrates multiple mechanisms of oxidative glutamate toxicity. Nat Commun 5, 3672 (2014).
155. Tian, Y.-M., Mole, D.R., Ratcliffe, P.J. & Gleadle, J.M. Characterization of different isoforms of the HIF prolyl hydroxylase PHD1 generated by alternative initiation. The Biochemical journal 397, 179–186 (2006).
160. Mikhaylova, O. et al. The von Hippel-Lindau tumor suppressor protein and Egl- 9-Type proline hydroxylases regulate the large subunit of RNA polymerase II in response to oxidative stress. Molecular and cellular biology 28, 2701–2717 (2008).
162. Siddiq, A., Aminova, L.R. & Ratan, R.R. Hypoxia inducible factor prolyl 4- hydroxylase enzymes: center stage in the battle against hypoxia, metabolic compromise and oxidative stress. Neurochemical research 32, 931–946 (2007).
164. Yang, W.S. & Stockwell, B.R. Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells. Chemistry & biology 15, 234–245 (2008).
171. Tobaben, S. et al. Bid-mediated mitochondrial damage is a key mechanism in glutamate-induced oxidative stress and AIF-dependent cell death in immortalized HT-22 hippocampal neurons. Cell Death Differ. 18, 282–292 (2011).
175. Karuppagounder, S.S. & Ratan, R.R. Hypoxia-inducible factor prolyl hydroxylase inhibition: robust new target or another big bust for stroke therapeutics? J. Cereb. Blood Flow Metab. 32, 1347–1361 (2012).
179. Li, D., Bai, T. & Brorson, J.R. Adaptation to moderate hypoxia protects cortical neurons against ischemia-reperfusion injury and excitotoxicity independently of HIF-1α. Experimental neurology 230, 302–310 (2011).
193. Tomasevic, G., Shamloo, M., Israeli, D. & Wieloch, T. Activation of p53 and its target genes p21WAF1/Cip1 and PAG608/Wig-1 in ischemic preconditioning. Molecular Brain Research 70, 304–313 (1999).
194. Grohm, J., Plesnila, N. & Culmsee, C. Bid mediates fission, membrane permeabilization and peri-nuclear accumulation of mitochondria as a prerequisite for oxidative neuronal cell death. Brain Behav. Immun. 24, 831–838 (2010).
198. Kim, J.-w., Tchernyshyov, I., Semenza, G.L. & Dang, C.V. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell metabolism 3, 177–185 (2006).
199. Mendjargal, A. et al. Pifithrin-α, a pharmacological inhibitor of p53, downregulates lipopolysaccharide-induced nitric oxide production via impairment of the MyD88-independent pathway. Int. Immunopharmacol. 15, 671–678 (2013).
203. Rieker, C. et al. Nucleolar disruption in dopaminergic neurons leads to oxidative damage and parkinsonism through repression of mammalian target of rapamycin signaling. J. Neurosci. 31, 453–460 (2011).